12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Company News  |  Deals

Valeant Pharmaceuticals International deal

Valeant signed a binding agreement to acquire an undisclosed private Brazilian generics and OTC company for about BRL97 million ($56 million). According to Valeant, the...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >